MARKET WIRE NEWS
  1. Home
  2. Stock
  3. SMMT
  4. Message Board
  5. Summit Therapeutics Inc. (NASDAQ: SMMT) Read Post Read Post 204834 - Akesobio Claims Lung Cancer Drug Significantly Outperforms Keytruda
SMMT
Quote
Short
News
Articles
Message Board

Summit Therapeutics Inc. (NASDAQ: SMMT Message Board Post 204834

Recent SMMT Posts
Posted By: (investorshub) @axelvento

Posted on: Mar/17/2025 10:44:29

Akesobio claims lung cancer drug significantly outperforms Keytruda

Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175935989

Back to SMMT Board

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Message Board Posts

Recent SMMT Posts
investorshub : US Market News
Summit Therapeutics to Present at Upcoming Investor Conferences
investorshub : US Market News
Summit Therapeutics Reports Financial Results and Operational Progress
investorshub : US Market News
Summit Therapeutics Reports Inducement Grants Under Nasdaq Listing
investorshub : INV4
Summit Therapeutics Shares Climb Amid Rumored $15B Deal

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.